Organogenesis Inc.

NASDAQ: ORGO · Real-Time Price · USD
4.72
0.02 (0.43%)
At close: Aug 15, 2025, 3:59 PM
4.80
1.59%
After-hours: Aug 15, 2025, 05:16 PM EDT

Organogenesis Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-9.39M -18.84M 7.67M 12.33M -17.04M -2.1M -568K 3.17M 5.32M -2.97M 7.49M 215K 7.74M 87K 51.7M 12.58M 20.69M 9.94M
Depreciation & Amortization
4.58M 6.28M 6.42M 4.4M 4.2M 6.18M 6.33M 3.77M 3.46M 5.86M 4.55M 4.51M 4.55M 4.42M 4.82M 4.73M 3.74M 3.38M
Stock-Based Compensation
2.54M 3.37M 2.89M 2.71M 2.57M 2.41M 2.37M 2.42M 2.3M 1.91M 1.85M 1.7M 1.69M 1.3M 1.08M 1.04M 1.04M 698K
Other Working Capital
-15.79M -15.15M -1.17M -20.85M -1.6M 3.48M -12.8M 3.37M -1.05M -4.84M -9.89M -2.29M 1.75M -8.73M -3.17M 1.68M -1.53M -585K
Other Non-Cash Items
8.55M 11.24M 3.56M 5.29M 22.57M 4.06M 3.13M 1.11M 2.29M 1.94M 3.2M 7.59M 3.55M 2.5M 4.45M -230K 3.15M 2.71M
Deferred Income Tax
-1.03M -1.27M -2.83M -2.2M n/a n/a 2.01M 3.24M 1.9M n/a 1.98M n/a n/a n/a -31.98M 6.8M -1.71M 1.05M
Change in Working Capital
-38.12M -20.71M -6.78M -13.85M -7.56M -20.7M -2.65M 3.02M -6.62M -11.83M -11.28M -8.56M -7.34M -6.9M -12.13M 2.93M -9.25M -19.26M
Operating Cash Flow
-32.87M -19.93M 10.94M 8.7M 4.74M -10.16M 10.61M 16.73M 8.65M -5.08M 7.8M 5.45M 10.2M 1.41M 17.95M 27.85M 17.66M -1.48M
Capital Expenditures
-3.64M -3.63M -3.36M -2.57M -1.88M -2.22M -3.32M -5.98M -7.5M -7.56M -10.66M -10.4M -6.17M -6.67M -5.23M -16.7M -4.33M -4.96M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -1.66M 828K 828K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a 1.66M -828K -828K n/a n/a n/a n/a n/a n/a n/a -179K 179K
Investing Cash Flow
-3.64M -3.63M -3.36M -2.57M -1.88M -2.22M -3.32M -5.98M -7.5M -7.56M -10.66M -10.4M -6.17M -6.67M -5.23M -16.7M -4.51M -4.78M
Debt Repayment
-288K -285K -62.62M -1.68M -1.67M -1.67M -1.78M -1.44M -1.02M -938K -1.88M n/a -570K -568K -1M 360K -699K -675K
Common Stock Repurchased
n/a n/a -25.48M n/a n/a n/a 333K n/a n/a n/a n/a -2K -158K n/a n/a n/a n/a n/a
Dividend Paid
-2.81M n/a -1.8M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
2.81M -1.8M 98.25M 1K -54K -1.12M 1K -1K -34K -298K n/a 26K 985K -197K 83K 910K -99K 84K
Financial Cash Flow
-288K -2.06M 33.65M -1.68M -1.73M -2.61M -1.78M -1.44M -1.05M -1.24M -1.88M 26K 415K -765K -917K 1.27M -798K -591K
Net Cash Flow
-36.8M -25.62M 41.23M 4.45M 1.13M -14.99M 5.51M 9.32M 93K -13.88M -4.73M -4.92M 4.44M -6.03M 11.8M 12.42M 12.35M -6.85M
Free Cash Flow
-36.51M -23.56M 7.58M 6.13M 2.86M -12.38M 7.29M 10.76M 1.15M -12.64M -2.86M -4.95M 4.03M -5.26M 12.72M 11.15M 13.33M -6.44M